You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 65 No. 10, October 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Dementias
 •Prion Diseases
 •Diagnosis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Voltage-Gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob Disease

Michael D. Geschwind, MD, PhD; K. Meng Tan, MD; Vanda A. Lennon, MD, PhD; Ramon F. Barajas Jr, BS; Aissa Haman, MD; Christopher J. Klein, MD; S. Andrew Josephson, MD; Sean J. Pittock, MD

Arch Neurol. 2008;65(10):1341-1346.

Background  Rapidly progressive dementia has a variety of causes, including Creutzfeldt-Jakob disease (CJD) and neuronal voltage-gated potassium channel (VGKC) autoantibody–associated encephalopathy.

Objective  To describe patients thought initially to have CJD but found subsequently to have immunotherapy-responsive VGKC autoimmunity.

Design  Observational, prospective case series.

Setting  Department of Neurology, Mayo Clinic, and the Memory and Aging Center, University of California, San Francisco.

Patients  A clinical serologic cohort of 15 patients referred for paraneoplastic autoantibody evaluation. Seven patients were evaluated clinically by at least one of us. Clinical information for the remaining patients was obtained by physician interview or medical record review.

Main Outcome Measures  Clinical features, magnetic resonance imaging abnormalities, electroencephalographic patterns, cerebrospinal fluid analyses, and responses to immunomodulatory therapy.

Results  All the patients presented subacutely with neurologic manifestations, including rapidly progressive dementia, myoclonus, extrapyramidal dysfunction, visual hallucinations, psychiatric disturbance, and seizures; most (60%) satisfied World Health Organization diagnostic criteria for CJD. Magnetic resonance imaging abnormalities included cerebral cortical diffusion-weighted imaging hyperintensities. Electroencephalographic abnormalities included diffuse slowing, frontal intermittent rhythmic delta activity, and focal epileptogenic activity but not periodic sharp wave complexes. Cerebrospinal fluid 14-3-3 protein or neuron-specific enolase levels were elevated in 5 of 8 patients. Hyponatremia was common (60%). Neoplasia was confirmed histologically in 5 patients (33%) and was suspected in another 5. Most patients' conditions (92%) improved after immunomodulatory therapy.

Conclusions  Clinical, radiologic, electrophysiologic, and laboratory findings in VGKC autoantibody–associated encephalopathy may be confused with those of CJD. Serologic evaluation for markers of neurologic autoimmunity, including VGKC autoantibodies, may be warranted in suspected CJD cases.


Author Affiliations: Memory and Aging Center, Department of Neurology, University of California, San Francisco (Drs Geschwind, Haman, and Josephson and Mr Barajas); and Departments of Laboratory Medicine and Pathology (Drs Tan, Lennon, and Pittock), Neurology (Drs Lennon, Klein, and Pittock), and Immunology (Dr Lennon), Mayo Clinic College of Medicine, Rochester, Minnesota.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(10):1278-1280.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Lancaster et al.
Neurology 2011;77:179-189.
ABSTRACT | FULL TEXT  

Sleep Manifestations of Voltage-Gated Potassium Channel Complex Autoimmunity
Cornelius et al.
Arch Neurol 2011;68:733-738.
ABSTRACT | FULL TEXT  

Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias
Vitali et al.
Neurology 2011;76:1711-1719.
ABSTRACT | FULL TEXT  

Creutzfeldt-Jacob disease mimics, or how to sort out the subacute encephalopathy patient
Murray
Postgrad. Med. J. 2011;87:369-378.
ABSTRACT | FULL TEXT  

Creutzfeldt-Jacob disease mimics, or how to sort out the subacute encephalopathy patient
Murray
PN 2011;11:19-28.
ABSTRACT | FULL TEXT  

Peripheral nerve hyperexcitability: A clinical and immunologic study of 38 patients
Rubio-Agusti et al.
Neurology 2011;76:172-178.
ABSTRACT | FULL TEXT  

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia
Irani et al.
Brain 2010;133:2734-2748.
ABSTRACT | FULL TEXT  

Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Suzuki et al.
Arch Neurol 2009;66:1334-1338.
ABSTRACT | FULL TEXT  

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
Zerr et al.
Brain 2009;132:2659-2668.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.